Emiliangelo Ratti
Senior Vice President, Global Head of Neuroscience
Takeda

Passionate and inspirational leader with large strategic and operational experience in Pharma R&D in Europe, UK, USA and Japan.

Currently, SVP Global Head of Takeda’s Neuroscience Therapy Area with full accountability of the definition of the R&D Neuroscience therapy area strategy as well as its operational execution including registration and life cycle management.

Previously he has successfully founded NeRRe Therapeutics Ltd, a biotech spin-out company from GlaxoSmithKline (GSK) that is dedicated to the clinical development of a portfolio of neurokinin antagonists, a field in which he is a recognized world-expert. He has lead this new UK-based start-up as Founder and Chief Executive Officer.

Prior to this position he was SVP, Global Head of the Neurosciences Centre of Excellence for Drug Discovery at GlaxoSmithKline and member of GSK’s R&D Scientific Advisory Board. He was accountable for the Neuroscience drug discovery process ranging from target identification/validation all the way through candidate selection and Ph2b clinical development till commitment to Ph3 start.

Before this he was Drug Discovery Director for one of the three GlaxoWellcome Drug Discovery Groups based in Italy and Spain and Research Director of Glaxo Medicine Research Centre in Verona, Italy.

He has strong scientific and managerial skills and is passionate about building vibrant and highly productive organizations. He believes key ingredients to achieve this goal is by embracing multicultural diversity, both engaging and empowering people and fostering external partnerships.